nodes	percent_of_prediction	percent_of_DWPC	metapath
Glipizide—CYP2C9—Gefitinib—lung cancer	0.07	0.135	CbGbCtD
Glipizide—CYP2C9—Teniposide—lung cancer	0.0679	0.131	CbGbCtD
Glipizide—CYP3A4—Topotecan—lung cancer	0.0445	0.0856	CbGbCtD
Glipizide—CYP3A4—Gefitinib—lung cancer	0.0407	0.0783	CbGbCtD
Glipizide—CYP3A4—Teniposide—lung cancer	0.0395	0.076	CbGbCtD
Glipizide—CYP2C9—Paclitaxel—lung cancer	0.0379	0.0729	CbGbCtD
Glipizide—CYP3A4—Vinorelbine—lung cancer	0.0314	0.0603	CbGbCtD
Glipizide—CYP2C9—Cisplatin—lung cancer	0.0305	0.0586	CbGbCtD
Glipizide—CYP3A4—Crizotinib—lung cancer	0.025	0.048	CbGbCtD
Glipizide—CYP3A4—Erlotinib—lung cancer	0.0241	0.0463	CbGbCtD
Glipizide—CYP3A4—Paclitaxel—lung cancer	0.022	0.0424	CbGbCtD
Glipizide—CYP3A4—Irinotecan—lung cancer	0.0217	0.0418	CbGbCtD
Glipizide—CYP3A4—Vinblastine—lung cancer	0.0193	0.0372	CbGbCtD
Glipizide—CYP3A4—Etoposide—lung cancer	0.0174	0.0335	CbGbCtD
Glipizide—CYP3A4—Docetaxel—lung cancer	0.0159	0.0307	CbGbCtD
Glipizide—CYP3A4—Doxorubicin—lung cancer	0.0119	0.0228	CbGbCtD
Glipizide—PPARG—Irinotecan—Topotecan—lung cancer	0.00323	0.33	CbGdCrCtD
Glipizide—PPARG—Topotecan—Irinotecan—lung cancer	0.00268	0.274	CbGdCrCtD
Glipizide—PPARG—Etoposide—Teniposide—lung cancer	0.00267	0.272	CbGdCrCtD
Glipizide—Gliclazide—VEGFA—lung cancer	0.00231	0.366	CrCbGaD
Glipizide—Glyburide—ABCC3—lung cancer	0.00154	0.244	CrCbGaD
Glipizide—PPARG—Teniposide—Etoposide—lung cancer	0.00121	0.124	CbGdCrCtD
Glipizide—Glyburide—ABCG2—lung cancer	0.000749	0.118	CrCbGaD
Glipizide—Gliclazide—ALB—lung cancer	0.000622	0.0983	CrCbGaD
Glipizide—Chlorpropamide—ABCB1—lung cancer	0.000461	0.073	CrCbGaD
Glipizide—Glyburide—ALB—lung cancer	0.000327	0.0516	CrCbGaD
Glipizide—Glyburide—ABCB1—lung cancer	0.000312	0.0493	CrCbGaD
Glipizide—Confusional state—Etoposide—lung cancer	0.000294	0.0009	CcSEcCtD
Glipizide—Pain—Gemcitabine—lung cancer	0.000292	0.000894	CcSEcCtD
Glipizide—Constipation—Gemcitabine—lung cancer	0.000292	0.000894	CcSEcCtD
Glipizide—Nausea—Erlotinib—lung cancer	0.000292	0.000894	CcSEcCtD
Glipizide—Pancytopenia—Methotrexate—lung cancer	0.000291	0.000893	CcSEcCtD
Glipizide—Diarrhoea—Vinorelbine—lung cancer	0.000291	0.00089	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Cisplatin—lung cancer	0.00029	0.000888	CcSEcCtD
Glipizide—Feeling abnormal—Irinotecan—lung cancer	0.000289	0.000884	CcSEcCtD
Glipizide—Confusional state—Paclitaxel—lung cancer	0.000288	0.000882	CcSEcCtD
Glipizide—Dysuria—Methotrexate—lung cancer	0.000287	0.000879	CcSEcCtD
Glipizide—Gastrointestinal pain—Irinotecan—lung cancer	0.000286	0.000877	CcSEcCtD
Glipizide—Oedema—Paclitaxel—lung cancer	0.000286	0.000875	CcSEcCtD
Glipizide—Paraesthesia—Cisplatin—lung cancer	0.000285	0.000875	CcSEcCtD
Glipizide—Thrombocytopenia—Etoposide—lung cancer	0.000285	0.000874	CcSEcCtD
Glipizide—Muscle spasms—Docetaxel—lung cancer	0.000285	0.000874	CcSEcCtD
Glipizide—Dyspnoea—Cisplatin—lung cancer	0.000283	0.000869	CcSEcCtD
Glipizide—Hyperhidrosis—Etoposide—lung cancer	0.000282	0.000863	CcSEcCtD
Glipizide—Feeling abnormal—Gemcitabine—lung cancer	0.000281	0.000861	CcSEcCtD
Glipizide—Shock—Paclitaxel—lung cancer	0.000281	0.000861	CcSEcCtD
Glipizide—Dizziness—Vinorelbine—lung cancer	0.000281	0.00086	CcSEcCtD
Glipizide—Abdominal pain upper—Doxorubicin—lung cancer	0.000281	0.00086	CcSEcCtD
Glipizide—Photosensitivity reaction—Methotrexate—lung cancer	0.00028	0.000858	CcSEcCtD
Glipizide—Thrombocytopenia—Paclitaxel—lung cancer	0.00028	0.000857	CcSEcCtD
Glipizide—Anorexia—Etoposide—lung cancer	0.000278	0.000851	CcSEcCtD
Glipizide—Abdominal pain—Irinotecan—lung cancer	0.000277	0.000848	CcSEcCtD
Glipizide—Decreased appetite—Cisplatin—lung cancer	0.000276	0.000847	CcSEcCtD
Glipizide—Hyperhidrosis—Paclitaxel—lung cancer	0.000276	0.000846	CcSEcCtD
Glipizide—Gastrointestinal disorder—Cisplatin—lung cancer	0.000274	0.000841	CcSEcCtD
Glipizide—Drowsiness—Methotrexate—lung cancer	0.000274	0.000838	CcSEcCtD
Glipizide—Anorexia—Paclitaxel—lung cancer	0.000272	0.000834	CcSEcCtD
Glipizide—Pain—Cisplatin—lung cancer	0.000272	0.000833	CcSEcCtD
Glipizide—Vomiting—Vinorelbine—lung cancer	0.00027	0.000827	CcSEcCtD
Glipizide—Rash—Vinorelbine—lung cancer	0.000268	0.00082	CcSEcCtD
Glipizide—Dermatitis—Vinorelbine—lung cancer	0.000267	0.00082	CcSEcCtD
Glipizide—Headache—Vinorelbine—lung cancer	0.000266	0.000815	CcSEcCtD
Glipizide—Syncope—Docetaxel—lung cancer	0.000266	0.000815	CcSEcCtD
Glipizide—Conjunctivitis—Methotrexate—lung cancer	0.000266	0.000815	CcSEcCtD
Glipizide—Leukopenia—Docetaxel—lung cancer	0.000265	0.000814	CcSEcCtD
Glipizide—Sweating—Methotrexate—lung cancer	0.000262	0.000804	CcSEcCtD
Glipizide—Feeling abnormal—Cisplatin—lung cancer	0.000262	0.000803	CcSEcCtD
Glipizide—Paraesthesia—Etoposide—lung cancer	0.000262	0.000801	CcSEcCtD
Glipizide—Loss of consciousness—Docetaxel—lung cancer	0.000261	0.000799	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.00026	0.000797	CcSEcCtD
Glipizide—Dyspnoea—Etoposide—lung cancer	0.00026	0.000796	CcSEcCtD
Glipizide—Somnolence—Etoposide—lung cancer	0.000259	0.000793	CcSEcCtD
Glipizide—Hepatobiliary disease—Methotrexate—lung cancer	0.000259	0.000793	CcSEcCtD
Glipizide—Insomnia—Paclitaxel—lung cancer	0.000258	0.000792	CcSEcCtD
Glipizide—Hypersensitivity—Irinotecan—lung cancer	0.000258	0.000791	CcSEcCtD
Glipizide—Paraesthesia—Paclitaxel—lung cancer	0.000256	0.000786	CcSEcCtD
Glipizide—Hypertension—Docetaxel—lung cancer	0.000256	0.000785	CcSEcCtD
Glipizide—Agranulocytosis—Methotrexate—lung cancer	0.000255	0.000782	CcSEcCtD
Glipizide—Dyspnoea—Paclitaxel—lung cancer	0.000255	0.00078	CcSEcCtD
Glipizide—Somnolence—Paclitaxel—lung cancer	0.000254	0.000778	CcSEcCtD
Glipizide—Decreased appetite—Etoposide—lung cancer	0.000253	0.000776	CcSEcCtD
Glipizide—Arthralgia—Docetaxel—lung cancer	0.000253	0.000774	CcSEcCtD
Glipizide—Myalgia—Docetaxel—lung cancer	0.000253	0.000774	CcSEcCtD
Glipizide—Pancytopenia—Doxorubicin—lung cancer	0.000252	0.000773	CcSEcCtD
Glipizide—Nausea—Vinorelbine—lung cancer	0.000252	0.000773	CcSEcCtD
Glipizide—Gastrointestinal disorder—Etoposide—lung cancer	0.000251	0.000771	CcSEcCtD
Glipizide—Dyspepsia—Paclitaxel—lung cancer	0.000251	0.00077	CcSEcCtD
Glipizide—Asthenia—Irinotecan—lung cancer	0.000251	0.00077	CcSEcCtD
Glipizide—Constipation—Etoposide—lung cancer	0.000249	0.000763	CcSEcCtD
Glipizide—Pain—Etoposide—lung cancer	0.000249	0.000763	CcSEcCtD
Glipizide—Dysuria—Doxorubicin—lung cancer	0.000248	0.000761	CcSEcCtD
Glipizide—Decreased appetite—Paclitaxel—lung cancer	0.000248	0.000761	CcSEcCtD
Glipizide—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000247	0.000756	CcSEcCtD
Glipizide—Hepatitis—Methotrexate—lung cancer	0.000246	0.000753	CcSEcCtD
Glipizide—Asthenia—Gemcitabine—lung cancer	0.000245	0.00075	CcSEcCtD
Glipizide—Pain—Paclitaxel—lung cancer	0.000244	0.000748	CcSEcCtD
Glipizide—Constipation—Paclitaxel—lung cancer	0.000244	0.000748	CcSEcCtD
Glipizide—Confusional state—Docetaxel—lung cancer	0.000244	0.000748	CcSEcCtD
Glipizide—Pharyngitis—Methotrexate—lung cancer	0.000244	0.000747	CcSEcCtD
Glipizide—Photosensitivity reaction—Doxorubicin—lung cancer	0.000242	0.000743	CcSEcCtD
Glipizide—Oedema—Docetaxel—lung cancer	0.000242	0.000742	CcSEcCtD
Glipizide—Pruritus—Gemcitabine—lung cancer	0.000241	0.00074	CcSEcCtD
Glipizide—Feeling abnormal—Etoposide—lung cancer	0.00024	0.000736	CcSEcCtD
Glipizide—Diarrhoea—Irinotecan—lung cancer	0.00024	0.000734	CcSEcCtD
Glipizide—Gastrointestinal pain—Etoposide—lung cancer	0.000238	0.00073	CcSEcCtD
Glipizide—Shock—Docetaxel—lung cancer	0.000238	0.00073	CcSEcCtD
Glipizide—Thrombocytopenia—Docetaxel—lung cancer	0.000237	0.000726	CcSEcCtD
Glipizide—Drowsiness—Doxorubicin—lung cancer	0.000237	0.000726	CcSEcCtD
Glipizide—Visual impairment—Methotrexate—lung cancer	0.000237	0.000725	CcSEcCtD
Glipizide—Feeling abnormal—Paclitaxel—lung cancer	0.000235	0.000721	CcSEcCtD
Glipizide—Hypersensitivity—Cisplatin—lung cancer	0.000234	0.000718	CcSEcCtD
Glipizide—Gastrointestinal pain—Paclitaxel—lung cancer	0.000234	0.000716	CcSEcCtD
Glipizide—Diarrhoea—Gemcitabine—lung cancer	0.000233	0.000715	CcSEcCtD
Glipizide—Dizziness—Irinotecan—lung cancer	0.000232	0.00071	CcSEcCtD
Glipizide—Urticaria—Etoposide—lung cancer	0.000231	0.000709	CcSEcCtD
Glipizide—Jaundice—Doxorubicin—lung cancer	0.000231	0.000708	CcSEcCtD
Glipizide—Anorexia—Docetaxel—lung cancer	0.000231	0.000707	CcSEcCtD
Glipizide—Abdominal pain—Etoposide—lung cancer	0.00023	0.000706	CcSEcCtD
Glipizide—Conjunctivitis—Doxorubicin—lung cancer	0.00023	0.000706	CcSEcCtD
Glipizide—Eye disorder—Methotrexate—lung cancer	0.000229	0.000703	CcSEcCtD
Glipizide—Asthenia—Cisplatin—lung cancer	0.000228	0.000699	CcSEcCtD
Glipizide—Sweating—Doxorubicin—lung cancer	0.000227	0.000696	CcSEcCtD
Glipizide—Urticaria—Paclitaxel—lung cancer	0.000227	0.000695	CcSEcCtD
Glipizide—Abdominal pain—Paclitaxel—lung cancer	0.000226	0.000692	CcSEcCtD
Glipizide—Hepatobiliary disease—Doxorubicin—lung cancer	0.000224	0.000686	CcSEcCtD
Glipizide—Vomiting—Irinotecan—lung cancer	0.000223	0.000682	CcSEcCtD
Glipizide—Agranulocytosis—Doxorubicin—lung cancer	0.000221	0.000677	CcSEcCtD
Glipizide—Rash—Irinotecan—lung cancer	0.000221	0.000677	CcSEcCtD
Glipizide—Dermatitis—Irinotecan—lung cancer	0.000221	0.000676	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000221	0.000676	CcSEcCtD
Glipizide—Chills—Methotrexate—lung cancer	0.00022	0.000675	CcSEcCtD
Glipizide—Headache—Irinotecan—lung cancer	0.000219	0.000672	CcSEcCtD
Glipizide—Insomnia—Docetaxel—lung cancer	0.000219	0.000671	CcSEcCtD
Glipizide—Diarrhoea—Cisplatin—lung cancer	0.000218	0.000667	CcSEcCtD
Glipizide—Paraesthesia—Docetaxel—lung cancer	0.000217	0.000666	CcSEcCtD
Glipizide—Vomiting—Gemcitabine—lung cancer	0.000217	0.000665	CcSEcCtD
Glipizide—Dyspnoea—Docetaxel—lung cancer	0.000216	0.000661	CcSEcCtD
Glipizide—Somnolence—Docetaxel—lung cancer	0.000215	0.000659	CcSEcCtD
Glipizide—Rash—Gemcitabine—lung cancer	0.000215	0.000659	CcSEcCtD
Glipizide—Dermatitis—Gemcitabine—lung cancer	0.000215	0.000658	CcSEcCtD
Glipizide—Hypersensitivity—Etoposide—lung cancer	0.000215	0.000658	CcSEcCtD
Glipizide—Erythema—Methotrexate—lung cancer	0.000214	0.000655	CcSEcCtD
Glipizide—Headache—Gemcitabine—lung cancer	0.000214	0.000655	CcSEcCtD
Glipizide—Rhinitis—Doxorubicin—lung cancer	0.000213	0.000653	CcSEcCtD
Glipizide—Dyspepsia—Docetaxel—lung cancer	0.000213	0.000653	CcSEcCtD
Glipizide—Hepatitis—Doxorubicin—lung cancer	0.000213	0.000652	CcSEcCtD
Glipizide—Hypoaesthesia—Doxorubicin—lung cancer	0.000212	0.000648	CcSEcCtD
Glipizide—Pharyngitis—Doxorubicin—lung cancer	0.000211	0.000647	CcSEcCtD
Glipizide—Decreased appetite—Docetaxel—lung cancer	0.00021	0.000645	CcSEcCtD
Glipizide—Hypersensitivity—Paclitaxel—lung cancer	0.00021	0.000645	CcSEcCtD
Glipizide—Gastrointestinal disorder—Docetaxel—lung cancer	0.000209	0.00064	CcSEcCtD
Glipizide—Asthenia—Etoposide—lung cancer	0.000209	0.00064	CcSEcCtD
Glipizide—Nausea—Irinotecan—lung cancer	0.000208	0.000637	CcSEcCtD
Glipizide—Pain—Docetaxel—lung cancer	0.000207	0.000634	CcSEcCtD
Glipizide—Constipation—Docetaxel—lung cancer	0.000207	0.000634	CcSEcCtD
Glipizide—Pruritus—Etoposide—lung cancer	0.000206	0.000631	CcSEcCtD
Glipizide—Visual impairment—Doxorubicin—lung cancer	0.000205	0.000628	CcSEcCtD
Glipizide—Asthenia—Paclitaxel—lung cancer	0.000205	0.000628	CcSEcCtD
Glipizide—Nausea—Gemcitabine—lung cancer	0.000203	0.000621	CcSEcCtD
Glipizide—Vomiting—Cisplatin—lung cancer	0.000202	0.000619	CcSEcCtD
Glipizide—Pruritus—Paclitaxel—lung cancer	0.000202	0.000619	CcSEcCtD
Glipizide—Vision blurred—Methotrexate—lung cancer	0.000201	0.000617	CcSEcCtD
Glipizide—Rash—Cisplatin—lung cancer	0.0002	0.000614	CcSEcCtD
Glipizide—Dermatitis—Cisplatin—lung cancer	0.0002	0.000614	CcSEcCtD
Glipizide—Feeling abnormal—Docetaxel—lung cancer	0.000199	0.000611	CcSEcCtD
Glipizide—Diarrhoea—Etoposide—lung cancer	0.000199	0.000611	CcSEcCtD
Glipizide—Eye disorder—Doxorubicin—lung cancer	0.000199	0.000609	CcSEcCtD
Glipizide—Ill-defined disorder—Methotrexate—lung cancer	0.000198	0.000608	CcSEcCtD
Glipizide—Gastrointestinal pain—Docetaxel—lung cancer	0.000198	0.000607	CcSEcCtD
Glipizide—Flushing—Doxorubicin—lung cancer	0.000197	0.000605	CcSEcCtD
Glipizide—Diarrhoea—Paclitaxel—lung cancer	0.000195	0.000599	CcSEcCtD
Glipizide—Malaise—Methotrexate—lung cancer	0.000193	0.000591	CcSEcCtD
Glipizide—Dizziness—Etoposide—lung cancer	0.000193	0.00059	CcSEcCtD
Glipizide—Vertigo—Methotrexate—lung cancer	0.000192	0.000589	CcSEcCtD
Glipizide—Abdominal pain—Docetaxel—lung cancer	0.000191	0.000586	CcSEcCtD
Glipizide—Leukopenia—Methotrexate—lung cancer	0.000191	0.000586	CcSEcCtD
Glipizide—Chills—Doxorubicin—lung cancer	0.000191	0.000585	CcSEcCtD
Glipizide—Arrhythmia—Doxorubicin—lung cancer	0.00019	0.000582	CcSEcCtD
Glipizide—Dizziness—Paclitaxel—lung cancer	0.000189	0.000579	CcSEcCtD
Glipizide—Nausea—Cisplatin—lung cancer	0.000189	0.000579	CcSEcCtD
Glipizide—Vomiting—Etoposide—lung cancer	0.000185	0.000567	CcSEcCtD
Glipizide—Erythema—Doxorubicin—lung cancer	0.000185	0.000567	CcSEcCtD
Glipizide—Rash—Etoposide—lung cancer	0.000184	0.000563	CcSEcCtD
Glipizide—Dermatitis—Etoposide—lung cancer	0.000183	0.000562	CcSEcCtD
Glipizide—Headache—Etoposide—lung cancer	0.000182	0.000559	CcSEcCtD
Glipizide—Flatulence—Doxorubicin—lung cancer	0.000182	0.000559	CcSEcCtD
Glipizide—Arthralgia—Methotrexate—lung cancer	0.000182	0.000558	CcSEcCtD
Glipizide—Myalgia—Methotrexate—lung cancer	0.000182	0.000558	CcSEcCtD
Glipizide—Tension—Doxorubicin—lung cancer	0.000182	0.000557	CcSEcCtD
Glipizide—Vomiting—Paclitaxel—lung cancer	0.000182	0.000556	CcSEcCtD
Glipizide—Rash—Paclitaxel—lung cancer	0.00018	0.000552	CcSEcCtD
Glipizide—Dermatitis—Paclitaxel—lung cancer	0.00018	0.000551	CcSEcCtD
Glipizide—Discomfort—Methotrexate—lung cancer	0.00018	0.000551	CcSEcCtD
Glipizide—Nervousness—Doxorubicin—lung cancer	0.00018	0.000551	CcSEcCtD
Glipizide—Headache—Paclitaxel—lung cancer	0.000179	0.000548	CcSEcCtD
Glipizide—Hypersensitivity—Docetaxel—lung cancer	0.000178	0.000547	CcSEcCtD
Glipizide—Muscle spasms—Doxorubicin—lung cancer	0.000178	0.000545	CcSEcCtD
Glipizide—Confusional state—Methotrexate—lung cancer	0.000176	0.000539	CcSEcCtD
Glipizide—Vision blurred—Doxorubicin—lung cancer	0.000174	0.000535	CcSEcCtD
Glipizide—Asthenia—Docetaxel—lung cancer	0.000174	0.000532	CcSEcCtD
Glipizide—Nausea—Etoposide—lung cancer	0.000173	0.00053	CcSEcCtD
Glipizide—Ill-defined disorder—Doxorubicin—lung cancer	0.000172	0.000526	CcSEcCtD
Glipizide—Pruritus—Docetaxel—lung cancer	0.000171	0.000525	CcSEcCtD
Glipizide—Thrombocytopenia—Methotrexate—lung cancer	0.000171	0.000523	CcSEcCtD
Glipizide—Nausea—Paclitaxel—lung cancer	0.00017	0.00052	CcSEcCtD
Glipizide—Hyperhidrosis—Methotrexate—lung cancer	0.000169	0.000517	CcSEcCtD
Glipizide—Malaise—Doxorubicin—lung cancer	0.000167	0.000512	CcSEcCtD
Glipizide—Vertigo—Doxorubicin—lung cancer	0.000166	0.00051	CcSEcCtD
Glipizide—Anorexia—Methotrexate—lung cancer	0.000166	0.00051	CcSEcCtD
Glipizide—Syncope—Doxorubicin—lung cancer	0.000166	0.000509	CcSEcCtD
Glipizide—Leukopenia—Doxorubicin—lung cancer	0.000166	0.000508	CcSEcCtD
Glipizide—Diarrhoea—Docetaxel—lung cancer	0.000166	0.000508	CcSEcCtD
Glipizide—Loss of consciousness—Doxorubicin—lung cancer	0.000163	0.000499	CcSEcCtD
Glipizide—Dizziness—Docetaxel—lung cancer	0.00016	0.000491	CcSEcCtD
Glipizide—Hypertension—Doxorubicin—lung cancer	0.00016	0.00049	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000159	0.000487	CcSEcCtD
Glipizide—Insomnia—Methotrexate—lung cancer	0.000158	0.000484	CcSEcCtD
Glipizide—Arthralgia—Doxorubicin—lung cancer	0.000158	0.000483	CcSEcCtD
Glipizide—Myalgia—Doxorubicin—lung cancer	0.000158	0.000483	CcSEcCtD
Glipizide—Anxiety—Doxorubicin—lung cancer	0.000157	0.000481	CcSEcCtD
Glipizide—Paraesthesia—Methotrexate—lung cancer	0.000157	0.00048	CcSEcCtD
Glipizide—Discomfort—Doxorubicin—lung cancer	0.000156	0.000477	CcSEcCtD
Glipizide—Dyspnoea—Methotrexate—lung cancer	0.000156	0.000477	CcSEcCtD
Glipizide—Somnolence—Methotrexate—lung cancer	0.000155	0.000475	CcSEcCtD
Glipizide—Vomiting—Docetaxel—lung cancer	0.000154	0.000472	CcSEcCtD
Glipizide—Dyspepsia—Methotrexate—lung cancer	0.000154	0.000471	CcSEcCtD
Glipizide—Rash—Docetaxel—lung cancer	0.000153	0.000468	CcSEcCtD
Glipizide—Dermatitis—Docetaxel—lung cancer	0.000152	0.000467	CcSEcCtD
Glipizide—Confusional state—Doxorubicin—lung cancer	0.000152	0.000467	CcSEcCtD
Glipizide—Decreased appetite—Methotrexate—lung cancer	0.000152	0.000465	CcSEcCtD
Glipizide—Headache—Docetaxel—lung cancer	0.000152	0.000465	CcSEcCtD
Glipizide—Oedema—Doxorubicin—lung cancer	0.000151	0.000463	CcSEcCtD
Glipizide—Gastrointestinal disorder—Methotrexate—lung cancer	0.000151	0.000462	CcSEcCtD
Glipizide—Pain—Methotrexate—lung cancer	0.000149	0.000457	CcSEcCtD
Glipizide—Shock—Doxorubicin—lung cancer	0.000149	0.000455	CcSEcCtD
Glipizide—Thrombocytopenia—Doxorubicin—lung cancer	0.000148	0.000453	CcSEcCtD
Glipizide—Hyperhidrosis—Doxorubicin—lung cancer	0.000146	0.000448	CcSEcCtD
Glipizide—Anorexia—Doxorubicin—lung cancer	0.000144	0.000441	CcSEcCtD
Glipizide—Nausea—Docetaxel—lung cancer	0.000144	0.000441	CcSEcCtD
Glipizide—Feeling abnormal—Methotrexate—lung cancer	0.000144	0.000441	CcSEcCtD
Glipizide—Gastrointestinal pain—Methotrexate—lung cancer	0.000143	0.000437	CcSEcCtD
Glipizide—Urticaria—Methotrexate—lung cancer	0.000139	0.000425	CcSEcCtD
Glipizide—Abdominal pain—Methotrexate—lung cancer	0.000138	0.000423	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000138	0.000422	CcSEcCtD
Glipizide—Insomnia—Doxorubicin—lung cancer	0.000137	0.000419	CcSEcCtD
Glipizide—Paraesthesia—Doxorubicin—lung cancer	0.000136	0.000416	CcSEcCtD
Glipizide—Dyspnoea—Doxorubicin—lung cancer	0.000135	0.000413	CcSEcCtD
Glipizide—Somnolence—Doxorubicin—lung cancer	0.000134	0.000412	CcSEcCtD
Glipizide—Dyspepsia—Doxorubicin—lung cancer	0.000133	0.000407	CcSEcCtD
Glipizide—Decreased appetite—Doxorubicin—lung cancer	0.000131	0.000402	CcSEcCtD
Glipizide—Gastrointestinal disorder—Doxorubicin—lung cancer	0.00013	0.0004	CcSEcCtD
Glipizide—Constipation—Doxorubicin—lung cancer	0.000129	0.000396	CcSEcCtD
Glipizide—Pain—Doxorubicin—lung cancer	0.000129	0.000396	CcSEcCtD
Glipizide—Hypersensitivity—Methotrexate—lung cancer	0.000129	0.000394	CcSEcCtD
Glipizide—Asthenia—Methotrexate—lung cancer	0.000125	0.000384	CcSEcCtD
Glipizide—Feeling abnormal—Doxorubicin—lung cancer	0.000124	0.000381	CcSEcCtD
Glipizide—Gastrointestinal pain—Doxorubicin—lung cancer	0.000124	0.000379	CcSEcCtD
Glipizide—Pruritus—Methotrexate—lung cancer	0.000123	0.000378	CcSEcCtD
Glipizide—Urticaria—Doxorubicin—lung cancer	0.00012	0.000368	CcSEcCtD
Glipizide—Abdominal pain—Doxorubicin—lung cancer	0.000119	0.000366	CcSEcCtD
Glipizide—Diarrhoea—Methotrexate—lung cancer	0.000119	0.000366	CcSEcCtD
Glipizide—Dizziness—Methotrexate—lung cancer	0.000115	0.000354	CcSEcCtD
Glipizide—Hypersensitivity—Doxorubicin—lung cancer	0.000111	0.000341	CcSEcCtD
Glipizide—Vomiting—Methotrexate—lung cancer	0.000111	0.00034	CcSEcCtD
Glipizide—Rash—Methotrexate—lung cancer	0.00011	0.000337	CcSEcCtD
Glipizide—Dermatitis—Methotrexate—lung cancer	0.00011	0.000337	CcSEcCtD
Glipizide—Headache—Methotrexate—lung cancer	0.000109	0.000335	CcSEcCtD
Glipizide—Asthenia—Doxorubicin—lung cancer	0.000108	0.000332	CcSEcCtD
Glipizide—Pruritus—Doxorubicin—lung cancer	0.000107	0.000328	CcSEcCtD
Glipizide—Nausea—Methotrexate—lung cancer	0.000104	0.000318	CcSEcCtD
Glipizide—Diarrhoea—Doxorubicin—lung cancer	0.000103	0.000317	CcSEcCtD
Glipizide—Dizziness—Doxorubicin—lung cancer	9.99e-05	0.000306	CcSEcCtD
Glipizide—Vomiting—Doxorubicin—lung cancer	9.61e-05	0.000294	CcSEcCtD
Glipizide—Rash—Doxorubicin—lung cancer	9.53e-05	0.000292	CcSEcCtD
Glipizide—Dermatitis—Doxorubicin—lung cancer	9.52e-05	0.000292	CcSEcCtD
Glipizide—Headache—Doxorubicin—lung cancer	9.46e-05	0.00029	CcSEcCtD
Glipizide—Nausea—Doxorubicin—lung cancer	8.97e-05	0.000275	CcSEcCtD
Glipizide—CYP2C9—Metabolism—AZIN2—lung cancer	6.92e-05	0.000502	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—COL4A3BP—lung cancer	6.92e-05	0.000502	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—CYP2E1—lung cancer	6.88e-05	0.0005	CbGpPWpGaD
Glipizide—ABCC8—Neuronal System—HRAS—lung cancer	6.85e-05	0.000498	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—NQO1—lung cancer	6.8e-05	0.000494	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—NOTCH3—lung cancer	6.78e-05	0.000492	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ALDOA—lung cancer	6.73e-05	0.000489	CbGpPWpGaD
Glipizide—ABCC8—Transmembrane transport of small molecules—RAF1—lung cancer	6.69e-05	0.000486	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—IL6R—lung cancer	6.68e-05	0.000485	CbGpPWpGaD
Glipizide—PPARG—Circadian rythm related genes—TP53—lung cancer	6.67e-05	0.000485	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—CREBBP—lung cancer	6.67e-05	0.000484	CbGpPWpGaD
Glipizide—KCNJ11—Neuronal System—HRAS—lung cancer	6.64e-05	0.000482	CbGpPWpGaD
Glipizide—PPARG—Metabolism—NCOA3—lung cancer	6.54e-05	0.000475	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	6.45e-05	0.000468	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	6.42e-05	0.000467	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—JUNB—lung cancer	6.42e-05	0.000466	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—MMP2—lung cancer	6.37e-05	0.000463	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—MAP2K1—lung cancer	6.36e-05	0.000462	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ADCY1—lung cancer	6.36e-05	0.000462	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ABCG2—lung cancer	6.36e-05	0.000462	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—STK11—lung cancer	6.32e-05	0.000459	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	6.25e-05	0.000454	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ENO2—lung cancer	6.24e-05	0.000453	CbGpPWpGaD
Glipizide—PPARG—Metabolism—HPGDS—lung cancer	6.24e-05	0.000453	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PPP2R1B—lung cancer	6.2e-05	0.00045	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—STK11—lung cancer	6.13e-05	0.000445	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—POMC—lung cancer	6.11e-05	0.000444	CbGpPWpGaD
Glipizide—PPARG—Circadian rythm related genes—IL6—lung cancer	6.11e-05	0.000444	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GSTT1—lung cancer	6.05e-05	0.000439	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GCLC—lung cancer	5.98e-05	0.000434	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CYP2A6—lung cancer	5.98e-05	0.000434	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	5.95e-05	0.000433	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—GSTP1—lung cancer	5.95e-05	0.000432	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ATP5H—lung cancer	5.88e-05	0.000427	CbGpPWpGaD
Glipizide—CYP3A4—Metapathway biotransformation—GSTP1—lung cancer	5.87e-05	0.000426	CbGpPWpGaD
Glipizide—CYP2C9—Biological oxidations—POMC—lung cancer	5.86e-05	0.000426	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—GSTP1—lung cancer	5.85e-05	0.000425	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—CAT—lung cancer	5.69e-05	0.000413	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—GSTP1—lung cancer	5.67e-05	0.000412	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ENO1—lung cancer	5.67e-05	0.000412	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	5.65e-05	0.00041	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—RAF1—lung cancer	5.64e-05	0.00041	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—ERBB2—lung cancer	5.58e-05	0.000406	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—ALB—lung cancer	5.57e-05	0.000405	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—ABCB1—lung cancer	5.54e-05	0.000402	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—CAT—lung cancer	5.52e-05	0.000401	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—GSTM1—lung cancer	5.47e-05	0.000397	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—TYMS—lung cancer	5.44e-05	0.000395	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	5.4e-05	0.000393	CbGpPWpGaD
Glipizide—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	5.4e-05	0.000392	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—GSTM1—lung cancer	5.38e-05	0.00039	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—ABCB1—lung cancer	5.37e-05	0.00039	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—TYMS—lung cancer	5.27e-05	0.000383	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PLBD1—lung cancer	5.24e-05	0.000381	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—GSTM1—lung cancer	5.21e-05	0.000379	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—CYP1A1—lung cancer	5.19e-05	0.000377	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	5.16e-05	0.000375	CbGpPWpGaD
Glipizide—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	5.11e-05	0.000372	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—CYP1A1—lung cancer	5.1e-05	0.00037	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CYP2E1—lung cancer	5.08e-05	0.000369	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—ERCC2—lung cancer	5.05e-05	0.000367	CbGpPWpGaD
Glipizide—PPARG—Metabolism—NQO1—lung cancer	5.03e-05	0.000365	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—CYP1A1—lung cancer	4.94e-05	0.000359	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	4.92e-05	0.000357	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—ERCC2—lung cancer	4.9e-05	0.000356	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	4.88e-05	0.000354	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—HSD17B10—lung cancer	4.79e-05	0.000348	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—MMP9—lung cancer	4.79e-05	0.000348	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—ERCC2—lung cancer	4.66e-05	0.000338	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—COL4A3BP—lung cancer	4.56e-05	0.000331	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—AZIN2—lung cancer	4.56e-05	0.000331	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—EP300—lung cancer	4.54e-05	0.00033	CbGpPWpGaD
Glipizide—PPARG—Metabolism—STK11—lung cancer	4.53e-05	0.000329	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CKB—lung cancer	4.46e-05	0.000324	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—SRC—lung cancer	4.42e-05	0.000321	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—APOA1—lung cancer	4.37e-05	0.000318	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—VEGFA—lung cancer	4.3e-05	0.000312	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—STAT3—lung cancer	4.26e-05	0.000309	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—PTEN—lung cancer	4.25e-05	0.000309	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—NRAS—lung cancer	4.25e-05	0.000309	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—APOA1—lung cancer	4.24e-05	0.000308	CbGpPWpGaD
Glipizide—PPARG—Generic Transcription Pathway—MYC—lung cancer	4.2e-05	0.000305	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GSTP1—lung cancer	4.19e-05	0.000304	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GSTM2—lung cancer	4.19e-05	0.000304	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CNDP2—lung cancer	4.19e-05	0.000304	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CAT—lung cancer	4.08e-05	0.000296	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—MTMR3—lung cancer	4.08e-05	0.000296	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—MAPK3—lung cancer	4.07e-05	0.000296	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—EP300—lung cancer	4.06e-05	0.000295	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PIK3CG—lung cancer	3.99e-05	0.00029	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PGAM1—lung cancer	3.97e-05	0.000289	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ABCB1—lung cancer	3.97e-05	0.000288	CbGpPWpGaD
Glipizide—PPARG—Metabolism—TYMS—lung cancer	3.9e-05	0.000283	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ATP5H—lung cancer	3.88e-05	0.000282	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—EGFR—lung cancer	3.87e-05	0.000281	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PIK3CG—lung cancer	3.87e-05	0.000281	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—POMC—lung cancer	3.87e-05	0.000281	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GSTM1—lung cancer	3.85e-05	0.00028	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—POMC—lung cancer	3.8e-05	0.000276	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CYP2A7—lung cancer	3.79e-05	0.000275	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—SDC4—lung cancer	3.71e-05	0.000269	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—CREBBP—lung cancer	3.7e-05	0.000269	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—POMC—lung cancer	3.68e-05	0.000268	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—KRAS—lung cancer	3.66e-05	0.000266	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CYP1A1—lung cancer	3.65e-05	0.000265	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ERCC2—lung cancer	3.62e-05	0.000263	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—CREBBP—lung cancer	3.59e-05	0.000261	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PIK3CD—lung cancer	3.51e-05	0.000255	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—ALB—lung cancer	3.46e-05	0.000252	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PLBD1—lung cancer	3.46e-05	0.000251	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—CREBBP—lung cancer	3.41e-05	0.000248	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PIK3CD—lung cancer	3.4e-05	0.000247	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—RRM1—lung cancer	3.38e-05	0.000245	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GSTA3—lung cancer	3.38e-05	0.000245	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—ALB—lung cancer	3.36e-05	0.000244	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—B4GALT5—lung cancer	3.18e-05	0.000231	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—HSD17B10—lung cancer	3.16e-05	0.00023	CbGpPWpGaD
Glipizide—PPARG—Metabolism—APOA1—lung cancer	3.13e-05	0.000228	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—HRAS—lung cancer	3.11e-05	0.000226	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GSTA4—lung cancer	3.09e-05	0.000224	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PIK3CB—lung cancer	3.06e-05	0.000222	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PTGS2—lung cancer	3.03e-05	0.00022	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	3.02e-05	0.000219	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GSTA2—lung cancer	3.01e-05	0.000219	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3e-05	0.000218	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—IL6—lung cancer	2.97e-05	0.000216	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PIK3CB—lung cancer	2.97e-05	0.000215	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CKB—lung cancer	2.94e-05	0.000214	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PTGS2—lung cancer	2.94e-05	0.000213	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GSTA1—lung cancer	2.9e-05	0.000211	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ABCC3—lung cancer	2.87e-05	0.000209	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PIK3CG—lung cancer	2.86e-05	0.000208	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—AKR1C1—lung cancer	2.78e-05	0.000202	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GSTM2—lung cancer	2.76e-05	0.000201	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CNDP2—lung cancer	2.76e-05	0.000201	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—AKT1—lung cancer	2.74e-05	0.000199	CbGpPWpGaD
Glipizide—PPARG—Metabolism—POMC—lung cancer	2.72e-05	0.000198	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—UGT1A1—lung cancer	2.7e-05	0.000196	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—MTMR3—lung cancer	2.69e-05	0.000195	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CREBBP—lung cancer	2.65e-05	0.000193	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PTEN—lung cancer	2.64e-05	0.000192	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PGAM1—lung cancer	2.62e-05	0.00019	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GNG11—lung cancer	2.6e-05	0.000189	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—lung cancer	2.59e-05	0.000188	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PTEN—lung cancer	2.56e-05	0.000186	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—EP300—lung cancer	2.52e-05	0.000183	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PIK3CD—lung cancer	2.51e-05	0.000183	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CYP2A7—lung cancer	2.5e-05	0.000182	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ALB—lung cancer	2.48e-05	0.00018	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ALDOA—lung cancer	2.48e-05	0.00018	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—SDC4—lung cancer	2.45e-05	0.000178	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—EP300—lung cancer	2.44e-05	0.000178	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—NCOA3—lung cancer	2.41e-05	0.000175	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	2.37e-05	0.000172	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ADCY1—lung cancer	2.34e-05	0.00017	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ABCG2—lung cancer	2.34e-05	0.00017	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—HPGDS—lung cancer	2.3e-05	0.000167	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ENO2—lung cancer	2.3e-05	0.000167	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PPP2R1B—lung cancer	2.28e-05	0.000166	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	2.25e-05	0.000164	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—RRM1—lung cancer	2.23e-05	0.000162	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GSTA3—lung cancer	2.23e-05	0.000162	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GSTT1—lung cancer	2.23e-05	0.000162	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GCLC—lung cancer	2.2e-05	0.00016	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CYP2A6—lung cancer	2.2e-05	0.00016	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	2.19e-05	0.000159	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PIK3CB—lung cancer	2.19e-05	0.000159	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PTGS2—lung cancer	2.17e-05	0.000158	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—B4GALT5—lung cancer	2.09e-05	0.000152	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ENO1—lung cancer	2.09e-05	0.000152	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—MAPK3—lung cancer	2.08e-05	0.000151	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	2.08e-05	0.000151	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	2.05e-05	0.000149	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GSTA4—lung cancer	2.04e-05	0.000148	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—MYC—lung cancer	2.02e-05	0.000147	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GSTA2—lung cancer	1.99e-05	0.000144	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GSTA1—lung cancer	1.92e-05	0.000139	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ABCC3—lung cancer	1.89e-05	0.000138	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PTEN—lung cancer	1.89e-05	0.000138	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CYP2E1—lung cancer	1.87e-05	0.000136	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PIK3CA—lung cancer	1.86e-05	0.000135	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—NQO1—lung cancer	1.85e-05	0.000134	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—AKR1C1—lung cancer	1.83e-05	0.000133	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.81e-05	0.000132	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PIK3CA—lung cancer	1.81e-05	0.000131	CbGpPWpGaD
Glipizide—PPARG—Metabolism—EP300—lung cancer	1.81e-05	0.000131	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.8e-05	0.00013	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—UGT1A1—lung cancer	1.78e-05	0.000129	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GNG11—lung cancer	1.72e-05	0.000125	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—STK11—lung cancer	1.67e-05	0.000121	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ALDOA—lung cancer	1.64e-05	0.000119	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—NCOA3—lung cancer	1.59e-05	0.000115	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.57e-05	0.000114	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ADCY1—lung cancer	1.54e-05	0.000112	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ABCG2—lung cancer	1.54e-05	0.000112	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GSTP1—lung cancer	1.54e-05	0.000112	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—AKT1—lung cancer	1.52e-05	0.000111	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—HPGDS—lung cancer	1.51e-05	0.00011	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ENO2—lung cancer	1.51e-05	0.00011	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PPP2R1B—lung cancer	1.5e-05	0.000109	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CAT—lung cancer	1.5e-05	0.000109	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.49e-05	0.000108	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—AKT1—lung cancer	1.48e-05	0.000107	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GSTT1—lung cancer	1.47e-05	0.000107	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ABCB1—lung cancer	1.46e-05	0.000106	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GCLC—lung cancer	1.45e-05	0.000105	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CYP2A6—lung cancer	1.45e-05	0.000105	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—TYMS—lung cancer	1.44e-05	0.000104	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GSTM1—lung cancer	1.42e-05	0.000103	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—AKT1—lung cancer	1.4e-05	0.000102	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ENO1—lung cancer	1.38e-05	0.0001	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CYP1A1—lung cancer	1.34e-05	9.77e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PIK3CA—lung cancer	1.34e-05	9.71e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ERCC2—lung cancer	1.33e-05	9.69e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CYP2E1—lung cancer	1.23e-05	8.97e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—NQO1—lung cancer	1.22e-05	8.87e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—APOA1—lung cancer	1.15e-05	8.38e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.1e-05	8.03e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—STK11—lung cancer	1.1e-05	7.99e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism—AKT1—lung cancer	1.09e-05	7.93e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PIK3CG—lung cancer	1.05e-05	7.65e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GSTP1—lung cancer	1.02e-05	7.4e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—POMC—lung cancer	1e-05	7.28e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CAT—lung cancer	9.91e-06	7.2e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CREBBP—lung cancer	9.77e-06	7.09e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ABCB1—lung cancer	9.64e-06	7e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—TYMS—lung cancer	9.46e-06	6.88e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GSTM1—lung cancer	9.36e-06	6.8e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PIK3CD—lung cancer	9.26e-06	6.73e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ALB—lung cancer	9.14e-06	6.64e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CYP1A1—lung cancer	8.87e-06	6.44e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ERCC2—lung cancer	8.8e-06	6.39e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PIK3CB—lung cancer	8.07e-06	5.86e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PTGS2—lung cancer	8e-06	5.81e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—APOA1—lung cancer	7.61e-06	5.53e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PTEN—lung cancer	6.97e-06	5.07e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PIK3CG—lung cancer	6.95e-06	5.05e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—EP300—lung cancer	6.65e-06	4.83e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—POMC—lung cancer	6.61e-06	4.8e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CREBBP—lung cancer	6.44e-06	4.68e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PIK3CD—lung cancer	6.11e-06	4.44e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ALB—lung cancer	6.03e-06	4.38e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PIK3CB—lung cancer	5.32e-06	3.87e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PTGS2—lung cancer	5.27e-06	3.83e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PIK3CA—lung cancer	4.92e-06	3.57e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PTEN—lung cancer	4.6e-06	3.34e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—EP300—lung cancer	4.39e-06	3.19e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—AKT1—lung cancer	4.02e-06	2.92e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PIK3CA—lung cancer	3.25e-06	2.36e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—AKT1—lung cancer	2.65e-06	1.93e-05	CbGpPWpGaD
